Click for best price
Rheumatoid Arthritis Drugs Market Size, Share 2022
Rheumatoid Arthritis Drugs include prescription and OTC.
This report contains market size and forecasts of Rheumatoid Arthritis Drugs in global, including the following market information:
Global Rheumatoid Arthritis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rheumatoid Arthritis Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Rheumatoid Arthritis Drugs companies in 2021 (%)
The global Rheumatoid Arthritis Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prescription Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rheumatoid Arthritis Drugs include AbbVie, Amgen, Bayer, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, F. Hoffmann-La Roche, Johnson and Johnson and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rheumatoid Arthritis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatoid Arthritis Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Rheumatoid Arthritis Drugs Market Segment Percentages, by Type, 2021 (%)
Prescription Drugs
Over-the-counter Drugs
Global Rheumatoid Arthritis Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Rheumatoid Arthritis Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Nursing Home
Other
Global Rheumatoid Arthritis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Rheumatoid Arthritis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rheumatoid Arthritis Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rheumatoid Arthritis Drugs revenues share in global market, 2021 (%)
Key companies Rheumatoid Arthritis Drugs sales in global market, 2017-2022 (Estimated), (MT)
Key companies Rheumatoid Arthritis Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Amgen
Bayer
Biogen
Boehringer Ingelheim
Bristol-Myers Squibb
F. Hoffmann-La Roche
Johnson and Johnson
Merck
Mitsubishi Tanabe Pharma
Novartis
Pfizer
UCB S.A
| Report Attributes |
Report Details |
| Report Title |
Rheumatoid Arthritis Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
77 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Rheumatoid Arthritis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rheumatoid Arthritis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rheumatoid Arthritis Drugs Overall Market Size
2.1 Global Rheumatoid Arthritis Drugs Market Size: 2021 VS 2028
2.2 Global Rheumatoid Arthritis Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Rheumatoid Arthritis Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Rheumatoid Arthritis Drugs Players in Global Market
3.2 Top Global Rheumatoid Arthritis Drugs Companies Ranked by Revenue
3.3 Global Rheumatoid Arthritis Drugs Revenue by Companies
3.4 Global Rheumatoid Arthritis Drugs Sales by Companies
3.5 Global Rheumatoid Arthritis Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Rheumatoid Arthritis Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Rheumatoid Arthritis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rheumatoid Arthritis Drugs Players in Global Market
3.8.1 List of Global Tier 1 Rheumatoid Arthritis Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Rheumatoid Arthritis Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Rheumatoid Arthritis Drugs Market Size Markets, 2021 & 2028
4.1.2 Prescription Drugs
4.1.3 Over-the-counter Drugs
4.2 By Type - Global Rheumatoid Arthritis Drugs Revenue & Forecasts
4.2.1 By Type - Global Rheumatoid Arthritis Drugs Revenue, 2017-2022
4.2.2 By Type - Global Rheumatoid Arthritis Drugs Revenue, 2023-2028
4.2.3 By Type - Global Rheumatoid Arthritis Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Rheumatoid Arthritis Drugs Sales & Forecasts
4.3.1 By Type - Global Rheumatoid Arthritis Drugs Sales, 2017-2022
4.3.2 By Type - Global Rheumatoid Arthritis Drugs Sales, 2023-2028
4.3.3 By Type - Global Rheumatoid Arthritis Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Rheumatoid Arthritis Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Rheumatoid Arthritis Drugs Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Nursing Home
5.1.5 Other
5.2 By Application - Global Rheumatoid Arthritis Drugs Revenue & Forecasts
5.2.1 By Application - Global Rheumatoid Arthritis Drugs Revenue, 2017-2022
5.2.2 By Application - Global Rheumatoid Arthritis Drugs Revenue, 2023-2028
5.2.3 By Application - Global Rheumatoid Arthritis Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Rheumatoid Arthritis Drugs Sales & Forecasts
5.3.1 By Application - Global Rheumatoid Arthritis Drugs Sales, 2017-2022
5.3.2 By Application - Global Rheumatoid Arthritis Drugs Sales, 2023-2028
5.3.3 By Application - Global Rheumatoid Arthritis Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Rheumatoid Arthritis Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Rheumatoid Arthritis Drugs Market Size, 2021 & 2028
6.2 By Region - Global Rheumatoid Arthritis Drugs Revenue & Forecasts
6.2.1 By Region - Global Rheumatoid Arthritis Drugs Revenue, 2017-2022
6.2.2 By Region - Global Rheumatoid Arthritis Drugs Revenue, 2023-2028
6.2.3 By Region - Global Rheumatoid Arthritis Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Rheumatoid Arthritis Drugs Sales & Forecasts
6.3.1 By Region - Global Rheumatoid Arthritis Drugs Sales, 2017-2022
6.3.2 By Region - Global Rheumatoid Arthritis Drugs Sales, 2023-2028
6.3.3 By Region - Global Rheumatoid Arthritis Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Rheumatoid Arthritis Drugs Revenue, 2017-2028
6.4.2 By Country - North America Rheumatoid Arthritis Drugs Sales, 2017-2028
6.4.3 US Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.4.4 Canada Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.4.5 Mexico Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Rheumatoid Arthritis Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Rheumatoid Arthritis Drugs Sales, 2017-2028
6.5.3 Germany Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.5.4 France Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.5.5 U.K. Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.5.6 Italy Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.5.7 Russia Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.5.9 Benelux Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Rheumatoid Arthritis Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Rheumatoid Arthritis Drugs Sales, 2017-2028
6.6.3 China Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.6.4 Japan Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.6.5 South Korea Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.6.7 India Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Rheumatoid Arthritis Drugs Revenue, 2017-2028
6.7.2 By Country - South America Rheumatoid Arthritis Drugs Sales, 2017-2028
6.7.3 Brazil Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.7.4 Argentina Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Rheumatoid Arthritis Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Rheumatoid Arthritis Drugs Sales, 2017-2028
6.8.3 Turkey Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.8.4 Israel Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Rheumatoid Arthritis Drugs Market Size, 2017-2028
6.8.6 UAE Rheumatoid Arthritis Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Rheumatoid Arthritis Drugs Major Product Offerings
7.1.4 AbbVie Rheumatoid Arthritis Drugs Sales and Revenue in Global (2017-2022)
7.1.5 AbbVie Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Rheumatoid Arthritis Drugs Major Product Offerings
7.2.4 Amgen Rheumatoid Arthritis Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Amgen Key News
7.3 Bayer
7.3.1 Bayer Corporate Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Rheumatoid Arthritis Drugs Major Product Offerings
7.3.4 Bayer Rheumatoid Arthritis Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Bayer Key News
7.4 Biogen
7.4.1 Biogen Corporate Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen Rheumatoid Arthritis Drugs Major Product Offerings
7.4.4 Biogen Rheumatoid Arthritis Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Biogen Key News
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Corporate Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Rheumatoid Arthritis Drugs Major Product Offerings
7.5.4 Boehringer Ingelheim Rheumatoid Arthritis Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Boehringer Ingelheim Key News
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Corporate Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Rheumatoid Arthritis Drugs Major Product Offerings
7.6.4 Bristol-Myers Squibb Rheumatoid Arthritis Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Bristol-Myers Squibb Key News
7.7 F. Hoffmann-La Roche
7.7.1 F. Hoffmann-La Roche Corporate Summary
7.7.2 F. Hoffmann-La Roche Business Overview
7.7.3 F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Major Product Offerings
7.7.4 F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Sales and Revenue in Global (2017-2022)
7.7.5 F. Hoffmann-La Roche Key News
7.8 Johnson and Johnson
7.8.1 Johnson and Johnson Corporate Summary
7.8.2 Johnson and Johnson Business Overview
7.8.3 Johnson and Johnson Rheumatoid Arthritis Drugs Major Product Offerings
7.8.4 Johnson and Johnson Rheumatoid Arthritis Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Johnson and Johnson Key News
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck Rheumatoid Arthritis Drugs Major Product Offerings
7.9.4 Merck Rheumatoid Arthritis Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Merck Key News
7.10 Mitsubishi Tanabe Pharma
7.10.1 Mitsubishi Tanabe Pharma Corporate Summary
7.10.2 Mitsubishi Tanabe Pharma Business Overview
7.10.3 Mitsubishi Tanabe Pharma Rheumatoid Arthritis Drugs Major Product Offerings
7.10.4 Mitsubishi Tanabe Pharma Rheumatoid Arthritis Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Mitsubishi Tanabe Pharma Key News
7.11 Novartis
7.11.1 Novartis Corporate Summary
7.11.2 Novartis Rheumatoid Arthritis Drugs Business Overview
7.11.3 Novartis Rheumatoid Arthritis Drugs Major Product Offerings
7.11.4 Novartis Rheumatoid Arthritis Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Novartis Key News
7.12 Pfizer
7.12.1 Pfizer Corporate Summary
7.12.2 Pfizer Rheumatoid Arthritis Drugs Business Overview
7.12.3 Pfizer Rheumatoid Arthritis Drugs Major Product Offerings
7.12.4 Pfizer Rheumatoid Arthritis Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Pfizer Key News
7.13 UCB S.A
7.13.1 UCB S.A Corporate Summary
7.13.2 UCB S.A Rheumatoid Arthritis Drugs Business Overview
7.13.3 UCB S.A Rheumatoid Arthritis Drugs Major Product Offerings
7.13.4 UCB S.A Rheumatoid Arthritis Drugs Sales and Revenue in Global (2017-2022)
7.13.5 UCB S.A Key News
8 Global Rheumatoid Arthritis Drugs Production Capacity, Analysis
8.1 Global Rheumatoid Arthritis Drugs Production Capacity, 2017-2028
8.2 Rheumatoid Arthritis Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Rheumatoid Arthritis Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Rheumatoid Arthritis Drugs Supply Chain Analysis
10.1 Rheumatoid Arthritis Drugs Industry Value Chain
10.2 Rheumatoid Arthritis Drugs Upstream Market
10.3 Rheumatoid Arthritis Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Rheumatoid Arthritis Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Rheumatoid Arthritis Drugs in Global Market
Table 2. Top Rheumatoid Arthritis Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Rheumatoid Arthritis Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Rheumatoid Arthritis Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Rheumatoid Arthritis Drugs Sales by Companies, (MT), 2017-2022
Table 6. Global Rheumatoid Arthritis Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Rheumatoid Arthritis Drugs Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Rheumatoid Arthritis Drugs Product Type
Table 9. List of Global Tier 1 Rheumatoid Arthritis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rheumatoid Arthritis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Rheumatoid Arthritis Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Rheumatoid Arthritis Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Rheumatoid Arthritis Drugs Sales (MT), 2017-2022
Table 15. By Type - Global Rheumatoid Arthritis Drugs Sales (MT), 2023-2028
Table 16. By Application ? Global Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Rheumatoid Arthritis Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Rheumatoid Arthritis Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Rheumatoid Arthritis Drugs Sales (MT), 2017-2022
Table 20. By Application - Global Rheumatoid Arthritis Drugs Sales (MT), 2023-2028
Table 21. By Region ? Global Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Rheumatoid Arthritis Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Rheumatoid Arthritis Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Rheumatoid Arthritis Drugs Sales (MT), 2017-2022
Table 25. By Region - Global Rheumatoid Arthritis Drugs Sales (MT), 2023-2028
Table 26. By Country - North America Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Rheumatoid Arthritis Drugs Sales, (MT), 2017-2022
Table 29. By Country - North America Rheumatoid Arthritis Drugs Sales, (MT), 2023-2028
Table 30. By Country - Europe Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Rheumatoid Arthritis Drugs Sales, (MT), 2017-2022
Table 33. By Country - Europe Rheumatoid Arthritis Drugs Sales, (MT), 2023-2028
Table 34. By Region - Asia Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Rheumatoid Arthritis Drugs Sales, (MT), 2017-2022
Table 37. By Region - Asia Rheumatoid Arthritis Drugs Sales, (MT), 2023-2028
Table 38. By Country - South America Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Rheumatoid Arthritis Drugs Sales, (MT), 2017-2022
Table 41. By Country - South America Rheumatoid Arthritis Drugs Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Rheumatoid Arthritis Drugs Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Rheumatoid Arthritis Drugs Sales, (MT), 2023-2028
Table 46. AbbVie Corporate Summary
Table 47. AbbVie Rheumatoid Arthritis Drugs Product Offerings
Table 48. AbbVie Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. Amgen Corporate Summary
Table 50. Amgen Rheumatoid Arthritis Drugs Product Offerings
Table 51. Amgen Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Bayer Corporate Summary
Table 53. Bayer Rheumatoid Arthritis Drugs Product Offerings
Table 54. Bayer Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Biogen Corporate Summary
Table 56. Biogen Rheumatoid Arthritis Drugs Product Offerings
Table 57. Biogen Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. Boehringer Ingelheim Corporate Summary
Table 59. Boehringer Ingelheim Rheumatoid Arthritis Drugs Product Offerings
Table 60. Boehringer Ingelheim Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. Bristol-Myers Squibb Corporate Summary
Table 62. Bristol-Myers Squibb Rheumatoid Arthritis Drugs Product Offerings
Table 63. Bristol-Myers Squibb Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. F. Hoffmann-La Roche Corporate Summary
Table 65. F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Product Offerings
Table 66. F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 67. Johnson and Johnson Corporate Summary
Table 68. Johnson and Johnson Rheumatoid Arthritis Drugs Product Offerings
Table 69. Johnson and Johnson Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 70. Merck Corporate Summary
Table 71. Merck Rheumatoid Arthritis Drugs Product Offerings
Table 72. Merck Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 73. Mitsubishi Tanabe Pharma Corporate Summary
Table 74. Mitsubishi Tanabe Pharma Rheumatoid Arthritis Drugs Product Offerings
Table 75. Mitsubishi Tanabe Pharma Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 76. Novartis Corporate Summary
Table 77. Novartis Rheumatoid Arthritis Drugs Product Offerings
Table 78. Novartis Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 79. Pfizer Corporate Summary
Table 80. Pfizer Rheumatoid Arthritis Drugs Product Offerings
Table 81. Pfizer Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 82. UCB S.A Corporate Summary
Table 83. UCB S.A Rheumatoid Arthritis Drugs Product Offerings
Table 84. UCB S.A Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 85. Rheumatoid Arthritis Drugs Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 86. Global Rheumatoid Arthritis Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Rheumatoid Arthritis Drugs Production by Region, 2017-2022 (MT)
Table 88. Global Rheumatoid Arthritis Drugs Production by Region, 2023-2028 (MT)
Table 89. Rheumatoid Arthritis Drugs Market Opportunities & Trends in Global Market
Table 90. Rheumatoid Arthritis Drugs Market Drivers in Global Market
Table 91. Rheumatoid Arthritis Drugs Market Restraints in Global Market
Table 92. Rheumatoid Arthritis Drugs Raw Materials
Table 93. Rheumatoid Arthritis Drugs Raw Materials Suppliers in Global Market
Table 94. Typical Rheumatoid Arthritis Drugs Downstream
Table 95. Rheumatoid Arthritis Drugs Downstream Clients in Global Market
Table 96. Rheumatoid Arthritis Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Rheumatoid Arthritis Drugs Segment by Type
Figure 2. Rheumatoid Arthritis Drugs Segment by Application
Figure 3. Global Rheumatoid Arthritis Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rheumatoid Arthritis Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rheumatoid Arthritis Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Rheumatoid Arthritis Drugs Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Rheumatoid Arthritis Drugs Revenue in 2021
Figure 9. By Type - Global Rheumatoid Arthritis Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Rheumatoid Arthritis Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Rheumatoid Arthritis Drugs Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Rheumatoid Arthritis Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Rheumatoid Arthritis Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Rheumatoid Arthritis Drugs Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Rheumatoid Arthritis Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Rheumatoid Arthritis Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Rheumatoid Arthritis Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Rheumatoid Arthritis Drugs Sales Market Share, 2017-2028
Figure 19. US Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Rheumatoid Arthritis Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Rheumatoid Arthritis Drugs Sales Market Share, 2017-2028
Figure 24. Germany Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Rheumatoid Arthritis Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Rheumatoid Arthritis Drugs Sales Market Share, 2017-2028
Figure 33. China Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Rheumatoid Arthritis Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Rheumatoid Arthritis Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Rheumatoid Arthritis Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Rheumatoid Arthritis Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Rheumatoid Arthritis Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Rheumatoid Arthritis Drugs Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Rheumatoid Arthritis Drugs by Region, 2021 VS 2028
Figure 50. Rheumatoid Arthritis Drugs Industry Value Chain
Figure 51. Marketing Channels
